An HPLC assay for daptomycin in serum

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1462-1463

  Tobin, Caroline M ^a   Darville, J M ^a   Lovering, A M ^a   Macgowan, A P ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Pharmacokinetics; Therapeutic drug monitoring

Indexed keywords

DAPTOMYCIN;

ACCURACY; AQUEOUS SOLUTION; BACTEREMIA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MEGADOSE; DRUG STABILITY; ENDOCARDITIS; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; SKIN INFECTION; TEMPERATURE ACCLIMATIZATION; TURNAROUND TIME; VIRUS INACTIVATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPTOMYCIN; HUMANS; SERUM;

EID: 56649086856     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn414     Document Type: Letter

References (5)

1. Tally FP, DeBruin MF. Development of daptomycin for Gram-positive infections. J Antimicrob Chemother 2000; 46: 523-6.
2. Rybak MJ, Bailey EM, Lamp KC et al. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for Gram-positive endocarditis and bacteraemia. Antimicrob Agents Chemother 1992; 36: 1109-14.
3. Tedesco KL, Rybak MJ. Daptomycin. Pharmacotherapy 2004; 24: 41-57.
4. Sauermann R, Rothenburger M, Graninger W et al. Daptomycin: A review 4 years after first approval. Pharmacology 2008; 81: 79-91.
5. Benvenuto M, Benziger DP, Yankelev S et al. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother 2006; 50: 3245-9.